0001615219-22-000087.txt : 20220531 0001615219-22-000087.hdr.sgml : 20220531 20220531171724 ACCESSION NUMBER: 0001615219-22-000087 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220526 FILED AS OF DATE: 20220531 DATE AS OF CHANGE: 20220531 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arthur David J. CENTRAL INDEX KEY: 0001769331 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36812 FILM NUMBER: 22984686 MAIL ADDRESS: STREET 1: 2450 HOLCOME BLVD. STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001615219 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465087339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: 346-772-0346 MAIL ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 FORMER COMPANY: FORMER CONFORMED NAME: Flex Pharma, Inc. DATE OF NAME CHANGE: 20140730 4 1 wf-form4_165403182105530.xml FORM 4 X0306 4 2022-05-26 0 0001615219 Salarius Pharmaceuticals, Inc. SLRX 0001769331 Arthur David J. C/O SALARIUS PHARMACEUTICALS, INC. 2450 HOLCOME BLVD., SUITE X HOUSTON TX 77021 1 1 0 0 Chief Executive Officer Common Stock 2022-05-26 4 P 0 3400 0.18 A 263074 D Common Stock 2022-05-26 4 P 0 18600 0.182 A 281674 D Common Stock 2022-05-26 4 P 0 708 0.18 A 282382 I By son Common Stock 2022-05-26 4 P 0 10392 0.1799 A 292774 I By son Common Stock 2022-05-26 4 P 0 10800 0.1843 A 303574 I By daughter The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. /s/Mark Rosenblum, as Attorney-in-Fact 2022-05-31